Literature DB >> 25673350

Technical outcomes and complications of pediatric ERCP.

Matthew J Giefer1, Richard A Kozarek2.   

Abstract

BACKGROUND: Previous reports have suggested that endoscopic retrograde cholangiopancreatography (ERCP) in pediatric patients is safe, but because the total number of cases reported in the literature remains small, questions remain regarding safety and outcomes of this procedure in children.
METHODS: Pediatric patients who underwent ERCP were identified from diagnostic to billing codes. Medical records were examined for age, gender, diagnosis codes, indication, type of sedation, findings, interventions, and complications. Descriptive statistics were prepared for data including frequencies, percentages for categorical variables, and means and standard deviations for quantitative variables. Extensions of logistic regression were used to examine the relationship between demographic and clinical characteristics and post-ERCP pancreatitis.
RESULTS: Four hundred and twenty-five ERCPs were performed on 276 pediatric patients. Patient's age ranged from 72 days to 18 years, and there was equal gender distribution. Targeted duct cannulation was achieved in over 95% of cases, and therapeutic interventions were common (81.3%). The most common indications were biliary obstruction (43.3%) and chronic pancreatitis (26.8%). The most common complication was post-ERCP pancreatitis which occurred in 26 cases (7.7%), and the majority was mild by consensus definition. Procedural characteristics significantly associated with post-ERCP pancreatitis included: pancreatogram, pancreatic sphincterotomy, pancreatic duct stenting, and pancreatic duct stricture dilation. Immediate post-sphincterotomy bleeding occurred twice (1.1%), and both cases were successfully treated during the procedure. There was one instance of a possible delayed sphincterotomy bleed. No mortality was observed.
CONCLUSIONS: This retrospective review is one of the larger ERCP series reported in the pediatric population and adds to the growing body of literature supporting that ERCP can be safely applied in younger patients by skilled endoscopists. The complication rate found in this series closely parallels that observed in adults. Prospective studies of pediatric ERCP are still required to more definitively define the safe and appropriate use of this procedure in children.

Entities:  

Keywords:  Bile duct stones; Children; Complications; ERCP; Outcomes; Pancreatitis

Mesh:

Year:  2015        PMID: 25673350     DOI: 10.1007/s00464-015-4105-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  22 in total

Review 1.  Mechanisms involved in the onset of post-ERCP pancreatitis.

Authors:  Raffaele Pezzilli; Elisabetta Romboli; Davide Campana; Roberto Corinaldesi
Journal:  JOP       Date:  2002-11

2.  The safety and efficacy of therapeutic ERCP in the pediatric population performed by adult gastroenterologists.

Authors:  Lauren Halvorson; Kevin Halsey; Peter Darwin; Eric Goldberg
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

3.  Endoscopic retrograde cholangiopancreatography is useful and safe in children.

Authors:  Catherine Paris; Jimmy Bejjani; Mona Beaunoyer; Alain Ouimet
Journal:  J Pediatr Surg       Date:  2010-05       Impact factor: 2.545

4.  Pediatric endoscopic retrograde cholangiopancreatography.

Authors:  P E Putnam; S A Kocoshis; S R Orenstein; R R Schade
Journal:  Am J Gastroenterol       Date:  1991-07       Impact factor: 10.864

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

6.  Endoscopic cannulation of the ampulla of vater: a preliminary report.

Authors:  W S McCune; P E Shorb; H Moscovitz
Journal:  Ann Surg       Date:  1968-05       Impact factor: 12.969

7.  Diagnostic and therapeutic ERCP in the pediatric age group.

Authors:  Hussain Issa; Ali Al-Haddad; Ahmed H Al-Salem
Journal:  Pediatr Surg Int       Date:  2006-12-06       Impact factor: 1.827

8.  ERCP can be safely and effectively performed by a pediatric gastroenterologist for choledocholithiasis in a pediatric facility.

Authors:  David M Troendle; Bradley A Barth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-11       Impact factor: 2.839

9.  Technical outcomes and complications of ERCP in children.

Authors:  Shyam Varadarajulu; C Mel Wilcox; Robert H Hawes; Peter B Cotton
Journal:  Gastrointest Endosc       Date:  2004-09       Impact factor: 9.427

10.  Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years.

Authors:  Peter B Cotton; Donald A Garrow; Joseph Gallagher; Joseph Romagnuolo
Journal:  Gastrointest Endosc       Date:  2009-03-14       Impact factor: 9.427

View more
  19 in total

1.  Percutaneous management of bile duct stones in children: results of 12 cases.

Authors:  Nevzat Özcan; Güven Kahrıman; Süreyya Burcu Görkem; Duran Arslan
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

2.  Pediatric endoscopic retrograde cholangiopancreatography.

Authors:  Yeşim Öztürk; Mesut Akarsu
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

3.  Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report From the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee.

Authors:  Maisam Abu-El-Haija; Soma Kumar; Jose Antonio Quiros; Keshawadhana Balakrishnan; Bradley Barth; Samuel Bitton; John F Eisses; Elsie Jazmin Foglio; Victor Fox; Denease Francis; Alvin Jay Freeman; Tanja Gonska; Amit S Grover; Sohail Z Husain; Rakesh Kumar; Sameer Lapsia; Tom Lin; Quin Y Liu; Asim Maqbool; Zachary M Sellers; Flora Szabo; Aliye Uc; Steven L Werlin; Veronique D Morinville
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

4.  Endoscopic treatment of chronic pancreatitis in pediatric population: Long-term efficacy and safety.

Authors:  D Kohoutova; A Tringali; G Papparella; V Perri; I Boškoski; J Hamanaka; G Costamagna
Journal:  United European Gastroenterol J       Date:  2018-12-05       Impact factor: 4.623

5.  Total Pancreatectomy With Islet Autotransplantation Resolves Pain in Young Children With Severe Chronic Pancreatitis.

Authors:  Melena D Bellin; Gregory P Forlenza; Kaustav Majumder; Megan Berger; Martin L Freeman; Gregory J Beilman; Ty B Dunn; Timothy L Pruett; Michael Murati; Joshua J Wilhelm; Marie Cook; David E R Sutherland; Sarah J Schwarzenberg; Srinath Chinnakotla
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-03       Impact factor: 2.839

Review 6.  Percutaneous Management of Biliary Stones.

Authors:  Nevzat Ozcan; Ahsun Riaz; Guven Kahriman
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

7.  Risk factor of bleeding after endoscopic sphincterotomy in average risk patients.

Authors:  Sang Soo Bae; Dong Wook Lee; Jimin Han; Ho Gak Kim
Journal:  Surg Endosc       Date:  2019-01-02       Impact factor: 4.584

Review 8.  Complications of Endoscopic Retrograde Cholangiopancreatography in Pediatric Patients; A Systematic Literature Review and Meta-Analysis.

Authors:  Danielle Usatin; Melissa Fernandes; Isabel E Allen; Emily R Perito; James Ostroff; Melvin B Heyman
Journal:  J Pediatr       Date:  2016-09-20       Impact factor: 4.406

Review 9.  Endoscopic retrograde cholangiopancreatography in children: Retrospective series with a long-term follow-up and literature review.

Authors:  Yavor Asenov; Melih Akın; Serdar Cantez; Feryal Gün Soysal; Yaman Tekant
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

10.  ERCP in infants, children and adolescents is feasible and safe: results from a tertiary care center.

Authors:  Jasmin Felux; Ekkehard Sturm; Andreas Busch; Emanuel Zerabruck; Florian Graepler; Dietmar Stüker; Andreas Manger; Hans-Joachim Kirschner; Gunnar Blumenstock; Nisar P Malek; Martin Goetz
Journal:  United European Gastroenterol J       Date:  2017-01-11       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.